Literature DB >> 8551486

White coat effect in treated hypertensive patients: sex differences.

M G Myers1, R A Reeves.   

Abstract

Ambulatory blood pressure recordings were performed in patients receiving anti-hypertensive therapy to determine the prevalence of a white coat effect and to evaluate the importance of the sex of the patients with higher office vs. ambulatory blood pressure (BP) readings. A white coat effect (office--ambulatory BP > or = 20/10 mm Hg) was present in 106 of 152 treated hypertensive patients who had a mean office BP (mm Hg) of 174 +/- 2/94 +/- 1 compared with a mean awake ambulatory BP of 137 +/- 2/81 +/- 1 (P < 0.001). A severe white coat effect (office--ambulatory BP > or = 40/20 mm Hg) was observed in 49 of 152 patients with office BP (183 +/- 3/96 +/- 2) being higher (P < 0.001) than mean awake ambulatory BP (134 +/- 2/77 +/- 1). A white coat effect was present in 70 of 87 women but only in 36 of 65 men (P < 0.001). Similarly, a severe white coat effect was seen in 41 of 87 women but only in 8 of 65 men (P < 0.001). Female sex and office SBP were significantly (P < 0.001) correlated with the presence of a white coat or severe white coat effect. Thus, female patients with treated hypertension are more likely than men to have a white coat component to their high office BP readings. These sex differences in white coat effect should be considered in future studies involving patients with hypertension based on high office readings.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8551486

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  9 in total

1.  ABPM Induced Alarm Reaction: A Possible Cause of Overestimation of Daytime Blood Pressure Values Reduced By Treatment with Beta-Blockers.

Authors:  Francesco Salvo; Chiara Lonati; Monica Albano; Paolo Fogliacco; Andrea Riccardo Errani; Cinzia Vallo; Michele Berardi; Vito Meinero; Carlo Lorenzo Muzzulini; Alberto Morganti
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-06-06

Review 2.  Treatment of white coat hypertension.

Authors:  S G Chrysant
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

3.  Prevalence and predictors of white-coat response in patients with treated hypertension.

Authors:  M B MacDonald; G P Laing; M P Wilson; T W Wilson
Journal:  CMAJ       Date:  1999-08-10       Impact factor: 8.262

4.  Preventing misdiagnosis of ambulatory hypertension: algorithm using office and home blood pressures.

Authors:  Daichi Shimbo; Sujith Kuruvilla; Donald Haas; Thomas G Pickering; Joseph E Schwartz; William Gerin
Journal:  J Hypertens       Date:  2009-09       Impact factor: 4.844

5.  Implications of ambulatory blood pressure monitoring substudies on the interpretation of clinical trials in hypertension: should the threshold for drug therapy be lower in older patients?

Authors:  Martin G Myers
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-27       Impact factor: 3.738

6.  The Blood Pressure "Uncertainty Range" - a pragmatic approach to overcome current diagnostic uncertainties (II).

Authors:  Cornel Pater
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-04-06

Review 7.  Automated Office Blood Pressure Measurement.

Authors:  Martin G Myers
Journal:  Korean Circ J       Date:  2018-04       Impact factor: 3.243

8.  Magnitude of the Difference Between Clinic and Ambulatory Blood Pressures and Risk of Adverse Outcomes in Patients With Chronic Kidney Disease.

Authors:  Elaine Ku; Raymond K Hsu; Delphine S Tuot; Se Ri Bae; Michael S Lipkowitz; Miroslaw J Smogorzewski; Barbara A Grimes; Matthew R Weir
Journal:  J Am Heart Assoc       Date:  2019-05-07       Impact factor: 5.501

9.  Prevalence and Predictors of White Coat Hypertension among Newly-Diagnosed Hypertensive Patients in a Tertiary Health Centre in Nigeria.

Authors:  Bolade Dele-Ojo; Philip Kolo; Ayodele Ogunmodede; Haleema Bello; Ibraheem Katibi; Ayodele Omotoso; Samuel Dada
Journal:  Ethiop J Health Sci       Date:  2019-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.